Search clinical trials for: JAK2 inhibitor RUXOLITINIB
Total 68022 results
-
Bristol-Myers SquibbTerminated
-
Matthew J KosterEli Lilly and CompanyCompleted
-
Novartis PharmaceuticalsCompletedIdiopathic Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia-Vera MyelofibrosisUnited Kingdom, Ireland, Germany, Italy, France
-
Shanghai Zhongshan HospitalUnknownPortal Hypertension | Myeloproliferative Neoplasm | Gastroesophageal Varices | Portal Caver CavernomaChina
-
Karyopharm Therapeutics IncActive, not recruitingMyelofibrosisSpain, China, Poland, United States, France, Greece, Italy
-
Philipps University Marburg Medical CenterCompletedCOVID | ARDS, HumanGermany
-
CelgeneCompletedMyelofibrosis | Myeloid Metaplasia | Myelofibrosis With Myeloid MetaplasiaUnited States, Italy, United Kingdom, Austria, Spain
-
M.D. Anderson Cancer CenterCephalonCompleted
-
PharmaEssentiaMedpace, Inc.; EPS International; Brightech InternationalActive, not recruitingEssential ThrombocythemiaUnited States, Canada, Korea, Republic of, China, Hong Kong, Singapore, Taiwan, Japan
-
Karyopharm Therapeutics IncNot yet recruitingMyelofibrosis | Moderate Thrombocytopenia
-
Assiut UniversityUnknownDetection of PCM1-JAK2 Fusion Gene by FISH in the Two Types of t-MDS/AML and Relationship Between PCM1-JAK2 Fusion Gene and Cumulative Dose, Dose Intensity
-
University of Michigan Rogel Cancer CenterTerminatedLymphoproliferative Disorders | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Lymphoma, T-Cell, Cutaneous | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Lymphoma, T-Cell, PeripheralUnited States
-
Swiss Group for Clinical Cancer ResearchCompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Myeloproliferative NeoplasmSwitzerland
-
William ShomaliIncyte CorporationRecruitingEosinophilia | Hypereosinophilic Syndrome | Blasts More Than 5 Percent of Bone Marrow Nucleated Cells | Splenomegaly | Hepatomegaly | Chronic Eosinophilic Leukemia, Not Otherwise Specified | JAK2 Gene Mutation | BCR-JAK2 Fusion Protein Expression | Blasts 20 Percent or Less of Peripheral Blood White... and other conditionsUnited States
-
CelgeneRecruitingPrimary Myelofibrosis | Myeloproliferative Disorders | Anemia | Myelofibrosis | Post-Polycythemia Vera MyelofibrosisFrance, Belgium, Spain, Australia, Canada, United States, Korea, Republic of, Romania, Japan, Israel, Italy, Austria, China, Czechia, Germany, Greece, Ireland, Poland, United Kingdom, Hong Kong, Hungary, Lebanon, Colombia, Argentina, Chile and more
-
Ronald HoffmanNational Cancer Institute (NCI); Myeloproliferative Disorders-Research ConsortiumTerminated
-
French Innovative Leukemia OrganisationCompleted
-
PharmaEssentiaNot yet recruitingPolycythemia Vera | Myeloproliferative Neoplasm
-
National Cancer Institute (NCI)Not yet recruitingKSHV Inflammatory Cytokine Syndrome (KICS) | Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman DiseaseUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedMyeloproliferative DisordersFrance
-
NYU Langone HealthWithdrawnCancer | Hematological MalignancyUnited States
-
Shanghai Zhongshan HospitalUnknownMyeloproliferative Neoplasm | Gastroesophageal Varices | JAK2 Mutation
-
Centre Hospitalier Annecy GenevoisCompleted
-
Fox Chase Cancer CenterRecruitingPrimary Myelofibrosis | Polycythemia Vera | Chronic Myelomonocytic Leukemia | Essential Thrombocytosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompleted
-
S*BIOCompletedMyelodysplastic Syndromes | Myelofibrosis | Chronic Myelomonocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaUnited States
-
Ascentage Pharma Group Inc.WithdrawnMyelofibrosisUnited States
-
M.D. Anderson Cancer CenterRecruitingPrimary Myelofibrosis | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | Myelofibrosis Transformation in Essential ThrombocythemiaUnited States
-
Ottawa Hospital Research InstituteCanadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR)... and other collaboratorsActive, not recruitingPrimary Myelofibrosis | Venous Thromboembolism (VTE) | Polycythemia Vera (PV) | Essential Thrombocythemia (ET) | JAK2 Mutation | Myeloproliferative Neoplasm (MPN)Canada
-
Novartis PharmaceuticalsTerminatedPrimary Myelofibrosis | Post-Polycythemia Vera | Post-Essential ThrombocytopeniaUnited States
-
Eli Lilly and CompanyCompleted
-
Stichting Hemato-Oncologie voor Volwassenen NederlandCTI BioPharma; Dutch Cancer SocietyActive, not recruitingMyelofibrosisNetherlands, Belgium
-
Tanta UniversityCompletedRheumatoid ArthritisEgypt
-
Mansoura UniversityCompletedResponse Assessment in Newly Diagnosed RA Patients at 3rd Month Was Evaluated by DAS28 and ACR in Relation to JAK ExpressionEgypt
-
National Jewish HealthCompletedChronic Beryllium Disease (CBD) | Beryllium Sensitization (BeS)United States
-
AstraZenecaTerminatedSolid MalignanciesUnited States
-
Incyte CorporationCompleted
-
The Lymphoma Academic Research OrganisationNovartisCompletedHodgkin's LymphomaFrance, Belgium
-
Ronald HoffmanNational Cancer Institute (NCI); Myeloproliferative Disorders-Research ConsortiumUnknownPolycythemia Vera | Essential Thrombocythemia | MyelofibrosisUnited States
-
S*BIOCompletedMyeloproliferative Disorders | Polycythemia Vera | Essential Thrombocythemia | MyelofibrosisUnited States, Australia
-
Royal Free Hospital NHS Foundation TrustEnrolling by invitationMyeloproliferative Neoplasm | Splanchnic Vein Thrombosis | JAK2 V617United Kingdom
-
Samsung Medical CenterCompletedPrimary Mediastinal Large B-cell Lymphoma | Relapsed or Refractory Hodgkin LymphomaKorea, Republic of
-
University Hospital, BrestRecruitingPolycythemia Vera | Essential Thrombocythemia | High-risk Patients | Prefibrotic/Early Primary Myelofibrosis | JAK2 V617FFrance
-
Actuate Therapeutics Inc.Completed
-
National Cancer Institute (NCI)Recruiting
-
University of WashingtonRecruitingAcute Myeloid Leukemia | Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative Neoplasm | Secondary Myelofibrosis | Myeloproliferative Neoplasm, UnclassifiableUnited States
-
University Medical Centre LjubljanaCompleted
-
National Cancer Institute (NCI)Not yet recruiting
-
Eli Lilly and CompanyIncyte CorporationCompletedArthritis, RheumatoidHungary, Romania, United States, Czechia, Croatia, Poland, Ukraine, Mexico, India